ArticleCancer reports (Hoboken, N.J.)2025
The Expression of lncRNAs EVADR and LUESCC in Colorectal Tumor Tissues and Their Association With the CRC Risk.
Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Expression of lncRNAs EVADR and LUESCC in Colorectal Tumor Tissues and Their Association With the CRC Risk.Cancer reports (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) is a prevalent form of cancer globally and ranks as the second most common cause of cancer-related deaths. Long non-coding RNAs (lncRNAs) are regulatory RNAs that influence gene expression. EVADR and LUESCC are two novel lncRNAs specifically expressed in tumors of glandular origin, such as the colon.
aimsThis study aimed to investigate the expression of EVADR and LUESCC in colorectal tumor tissues and evaluate their potential as diagnostic and prognostic biomarkers in CRC.
methodsFifty cases of colorectal tumor tissues, formalin-fixed, paraffin-embedded (FFPE) from individuals with sporadic CRC, referred from the Pathology Department of Imam Hossein Hospital in Tehran, Iran, were analyzed. The expression patterns of LUESCC and EVADR lncRNAs in CRC patients were examined.
resultsThe study reveals upregulation of LUESCC and EVADR lncRNAs in colorectal cancer (CRC) patients compared to normal tissues, with fold changes of 3.52 (p < 0.001) for LUESCC and 3.08 (p < 0.001) for EVADR. ROC curve analysis indicates an area under the curve (AUC) of 0.75 for LUESCC and 0.86 for EVADR, suggesting strong diagnostic potential. Additionally, differential expression analysis shows correlations between lncRNA levels and tumor differentiation grades.
conclusionThis study highlights the potential of LUESCC and EVADR lncRNAs as biomarkers for CRC diagnosis and prognosis. However, limitations include a small sample size that may affect the generalizability of the findings and a lack of functional assays to elucidate their roles in tumor biology. Further research is needed to validate these findings and explore the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.